Attention Disturbances, Depression, Healthy, Insomnia
Conditions
Brief summary
This study, based on preliminary experimental results, literature review, and expert consultations, developed the Attentional Rating Scale (ARS). The aim was to rapidly assess participants' attention and potential influencing factors. The research focused on the scale's reliability and validity among healthy adults. Additionally, the Attention Network Test (ANT) served as the gold standard for evaluating attention. The study attempted to identify correlations between various dimensions of attention and the three attentional networks.
Detailed description
1. To adiministrate 60 healthy subjects to evaluate internal consistency reliability. 2. To choose 20 cases for ARS retesting 7 days after the first ARS evaluation. 3. To evaluate the split half reliability through the Spearman Brown coefficient. 4. To apply principal component analysis for structural validity analysis. 5. Using the Attention Network Test (ANT) and Toronto Hospital Alertness Test (THE) as gold standards, the Pearson correlation coefficient was used for criterion validity analysis. 6. To administrate 60 patients with MDD, ADHD and insomnia disorder testing the discrimination validity of ARS.
Interventions
DIAGNOSTIC_TESTrating
rating scales, test ANT
Sponsors
Peking University Sixth Hospital
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
1. Major Depressive Disorder (MDD) or attention deficit hyperactivity disorder (ADHD) diagnosed according to DSM-5, or Chronic Insomnia Disorder diagnosed according to ICSD-3 2. Ages between 18 and 60 years old 3. Right-handed 4. Educational level ≥5 years or IQ ≥90, capable of understanding and reading Chinese.
Exclusion criteria
1. Currently diagnosed with any other DSM-5 mental disorders (according to MINI 7.0) or ICSD-3 sleep-wake disorders, apart from MDD, ADHD or insomnia disorder 2. Currently and past history of neurological disorders and physical illnesses with subjectives 3. Consumed alcohol in the week preceding the enrollment 4. Using antidepressants, antipsychotics, mood stabilizers, or other central nervous system-acting drugs for at least 4 weeks in the current episode 5. Undergoing any physical treatments such as ECT, neuromodulation therapy or Traditional Chinese Medicine treatment in the past 6 months 6. Refused to sign the informed consent form
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Developing Attention Rating Scale（ARS） | 3 months | The Attention Assessment Scale is developing as a tool to assess attention ability designed for self-rating scale. Its purpose is to swiftly evaluate the attention levels of adults. There are 30 items in ARS. The minimum value is 1 and maximum value is 5, and the higher scores mean a better outcome for attention ability. |
| Reliability and Validity of the Attention Assessment Scale. | 2 years | Reliability 1. Cronbach α of ARS should be above 0.8 that means good reliability. 2. The intra group correlation value for retesting reliability should be above 0.8 that means good retesting reliability. Validity 1. The split half reliability measured and factor analysis to test constuctive validity of ARS. 2. The correlation coefficient r with ANT and the correlation coefficient r with THAT should be statistic significant, that means good validity of attention ability for Attention Assessment Scale. |
Countries
China
Contacts
Primary ContactXinyang Zhang, master
Outcome results
None listed